The role of CB1 in intestinal permeability and inflammation

Endocannabinoids in the gastrointestinal tract

(2016) Yunna Lee et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The Endocannabinoid System and its Modulation by Phytocannabinoids

(2015) Vincenzo Di Marzo et al.   Neurotherapeutics

Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium

(2014) Luan C. Koay et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice

(2014) Stephanie Troy-Fioramonti et al.   DIABETES

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)

(2014) M. Sałaga et al.   Journal of Crohns & Colitis

Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability

(2013) B.S. Harvey et al.   CYTOKINE

Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model

(2013) B.S. Harvey et al.   CYTOKINE

Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor

(2013) Derek M. Shore et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prostaglandin ethanolamides attenuate damage in a human explant colitis model

(2013) Lauren L. Nicotra et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Tight junctions on the move: molecular mechanisms for epithelial barrier regulation

(2012) Le Shen   Annals of the New York Academy of Sciences

Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability

(2011) A Alhamoruni et al.   BRITISH JOURNAL OF PHARMACOLOGY

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease

(2011) A Di Sabatino et al.   Mucosal Immunology

Endocannabinoid biosynthesis and inactivation, from simple to complex

(2010) Giulio G. Muccioli   DRUG DISCOVERY TODAY

Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability

(2010) A. Alhamoruni et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Intestinal barrier function: Molecular regulation and disease pathogenesis

(2009) Katherine R. Groschwitz et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

CENTRAL CANNABINOID 1 RECEPTOR ANTAGONIST ADMINISTRATION PREVENTS ENDOTOXIC HYPOTENSION AFFECTING NOREPINEPHRINE RELEASE IN THE PREOPTIC ANTERIOR HYPOTHALAMIC AREA

(2009) Alex Villanueva et al.   SHOCK

Stem Cells, Self-Renewal, and Differentiation in the Intestinal Epithelium

(2008) Laurens G. van der Flier et al.   Annual Review of Physiology

‘Entourage’ effects ofN-palmitoylethanolamide andN-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors

(2008) W-SV Ho et al.   BRITISH JOURNAL OF PHARMACOLOGY